CNXC trades 107.3% below Wall Street's consensus target of $52.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CNXC achieves its forward estimates and maintains a stable P/E multiple of 2.1x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Concentrix Corporation (CNXC) has a Wall Street consensus price target of $52.00, based on estimates from 9 covering analysts. With the stock currently trading at $25.08, this represents a potential upside of +107.3%. The company has a market capitalization of $1.76B.
Analyst price targets range from a low of $52.00 to a high of $52.00, representing a 0% spread in expectations. The median target of $52.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CNXC trades at a trailing P/E of -1.2x and forward P/E of 2.1x. Analysts expect EPS to grow +156.8% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
TTECTTEC Holdings, Inc. | $104M | $2.14 | $34.17 | +1496.7% | Hold | 1.8x | 14 |
TASKTaskUs, Inc. | $443M | $4.91 | $10.50 | +113.8% | Buy | 3.7x | 11 |
IBEXIBEX Limited | $407M | $30.22 | $24.00 | -20.6% | Hold | 8.6x | 6 |
ACNAccenture plc | $80.3B | $130.54 | $236.31 | +81.0% | Buy | 9.4x | 53 |
GGenpact Limited | $4.8B | $28.25 | $42.00 | +48.7% | Hold | 6.9x | 40 |
EPAMEPAM Systems, Inc. | $4.0B | $76.64 | $144.63 | +88.7% | Buy | 5.9x | 37 |
CTSHCognizant Technology Solutions Corporation | $20.7B | $43.70 | $77.92 | +78.3% | Hold | 7.6x | 51 |
CRMSalesforce, Inc. | $124.3B | $151.78 | $265.75 | +75.1% | Buy | 12.9x | 97 |
NICENICE Ltd. | $5.1B | $84.68 | $118.80 | +40.3% | Buy | 7.6x | 23 |
TWLOTwilio Inc. | $28.2B | $186.17 | $197.08 | +5.9% | Buy | 32.6x | 52 |
Quick answers to the most common questions about buying CNXC stock.
The consensus Wall Street price target for CNXC is $52, representing 107.3% upside from the current price of $25.08. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CNXC has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 7 Buy/Strong Buy ratings. The consensus 12-month price target of $52 implies 107.3% upside from current levels.
With a forward P/E of 2.1418x, CNXC trades at a relatively low valuation. The consensus target of $52 implies 107.3% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $52 for CNXC, while the most conservative target is $52. The consensus of $52 represents the median expectation. These targets typically reflect 12-month expectations.
CNXC is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CNXC stock forecast based on 9 Wall Street analysts shows a consensus price target of $52, with estimates ranging from $52 (bear case) to $52 (bull case). The median consensus rating is "Buy".
CNXC trades at a forward P/E ratio of 2.1x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CNXC, with a "Buy" consensus rating and $52 price target (107.3% upside). 7 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CNXC analyst price targets range from $52 to $52, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $52 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.